Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antineoplastics Toxicity”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Large-scale testing (Phase 3)Ended earlyNCT00486213
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Who this might be right for
Dermatologic ComplicationsPalmar-plantar ErythrodysesthesiaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Centre, Singapore 210
Not applicableStudy completedNCT04528745
What this trial is testing

The Relationship Between Fat Free Mass and Toxicity of Cytostatics in Cancer Patients

Who this might be right for
Pancreas CancerColorectal Cancer
University of Copenhagen 52
Early research (Phase 1)Study completedNCT00838370
What this trial is testing

Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

Who this might be right for
Neoplasms
The Netherlands Cancer Institute 22
Not applicableStudy completedNCT00860041
What this trial is testing

Acute Pain Caused by Paclitaxel in Patients With Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityNeurotoxicityPain+1 more
Alliance for Clinical Trials in Oncology 306
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Post-approval studies (Phase 4)Ended earlyNCT00754767
What this trial is testing

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeurotoxicity
HealthPartners Institute 2
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Testing effectiveness (Phase 2)Study completedNCT00748215
What this trial is testing

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerDiarrhea
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Ended earlyNCT00503776
What this trial is testing

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Who this might be right for
DysphagiaHead and Neck CancerMucositis+1 more
Vanderbilt-Ingram Cancer Center 41
Not applicableStudy completedNCT00499798
What this trial is testing

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Looking for participantsNCT06237920
What this trial is testing

Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab

Who this might be right for
Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by Site+8 more
The Netherlands Cancer Institute 90
Not applicableTemporarily pausedNCT00695032
What this trial is testing

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Who this might be right for
Chemotherapeutic Agent ToxicityRenal ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Institut Claudius Regaud 80
Not applicableUnknownNCT00514345
What this trial is testing

CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Who this might be right for
Chemotherapeutic Agent ToxicitySarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group 300
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Not applicableStudy completedNCT00755313
What this trial is testing

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more
University of California, San Francisco 81
Not applicableActive Not RecruitingNCT07163286
What this trial is testing

Malnutrition and Sarcopenia Screening in Chemotherapy Patients

Who this might be right for
Nutrition Aspect of CancerSarcopeniaChemotherapeutic Agent Toxicity
Çanakkale Onsekiz Mart University 200
Large-scale testing (Phase 3)Ended earlyNCT00662688
What this trial is testing

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityPancreatic CancerThromboembolism
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT01273610
What this trial is testing

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsHER2/Neu PositiveGeriatric Health Services
City of Hope Medical Center 40
Not applicableUnknownNCT04962425
What this trial is testing

Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Cardiac ToxicityAntitumor DrugsBreast Cancer
Peking University Third Hospital 240
Post-approval studies (Phase 4)Looking for participantsNCT06183437
What this trial is testing

The STOP-MED CTRCD Trial

Who this might be right for
Heart FailureCardiotoxicityCardiac Toxicity+2 more
University Health Network, Toronto 335
Load More Results